Dr. Wynands helped build the academic and clinical foundations of the specialty in Canada
Search
Displaying 181 - 200 of 282
The University of Ottawa Heart Institute (UOHI) will host Epic MyChart Information Sessions for patients. Details below: Thursday, January 16, 2020 2 to 3 p.m. UOHI, 40 Ruskin Street, East Foustanellas (second floor, room number H-2368). Wednesday, January 29, 2020 4 to 5 p.m. UOHI, 40 Ruskin Street...
With major funding from Genome Canada and partnership with Roche Diagnostics International, Heart Institute researchers now poised to tackle an important health issue affecting millions of Canadians. OTTAWA, ON, March 9, 2021 – The University of Ottawa Heart Institute (UOHI) has been awarded nearly...
Dr. Kelly Cobey is the 2024 recipient of Nature’s John Maddox Prize
Rob deKemp, PhD, MASNC, wins the Abstract of the Year at the 2025 Society of Nuclear Medicine and Molecular Imaging annual meeting in New Orleans
A new trial co-led by the Ottawa Heart Institute and the Research Institute of the McGill University Health Centre shows that continuing these medications offers no added protection against stroke or embolic events compared with low-dose aspirin
The University of Ottawa Heart Institute Foundation is pleased to announce the appointment of Lianne Laing as the new executive director, effective June 30, 2020. Lianne Laing joins the Foundation after a successful broadcasting career at CTV/Bell Media Ottawa, and more recently as a communications...
June 30, 2020, OTTAWA – The University of Ottawa Heart Institute Foundation is pleased to announce the appointment of Lianne Laing as the new executive director, effective today. As the new executive director, Ms. Laing will report to the Foundation’s board of directors and the president and CEO of...
OTTAWA, May 11, 2021 — It was 45 years ago, on May 11, 1976, that the University of Ottawa Heart Institute (UOHI) opened its doors. Founded by visionary cardiac surgeon and researcher Dr. Wilbert J. Keon, what began as a department in The Ottawa Hospital has since flourished into Canada's largest...
Results of the trial are published in the New England Journal of Medicine Researchers at the University of Ottawa Heart Institute (UOHI) comparing the efficacy and safety of two inotropic medicines used to treat patients with cardiogenic shock conclude there is no clinically significant difference...
In a research letter published in the Journal of the American College of Cardiology, a group of researchers led by Dr. Marc Ruel of the University of Ottawa Heart Institute (UOHI) conclude that minimally invasive coronary artery bypass grafting (MICS CABG) has “favourable long-term outcomes” for...
NanoOntario is recognizing Emilio Alarcon, PhD, of the University of Ottawa Heart Institute with an award for outstanding early-career achievements in nano-related research and development. The scientist will accept his award and present a virtual lecture about his research, “ From chemical kinetics...
Cardiovascular disease (CVD) is the country’s leading cause of premature death in women. The Canadian Women’s Heart Health Alliance (CWHHA), a national network of women’s heart health experts and advocates powered by the Canadian Women’s Heart Health Centre (CWHHC) at the University of Ottawa Heart...
Scheduled email service downtime The University of Ottawa Heart Institute will be migrating to a new email platform. As a result, you will not be able to reach us via email from Friday, January 29 at 9 p.m. to Monday, February 1 at 6 a.m. In case of an emergency, please contact the UOHI...
UOHI-led study demonstrates RIPK1 gene is associated with obesity, and silencing its expression is a viable therapeutic approach to obesity and related diseases. Watch: Dr. Katey Rayner discusses her research. Scientists at the University of Ottawa Heart Institute have demonstrated that elevated...
Scientist in the Division of Cardiac Surgery, and Director of the Bio-Nanomaterials Chemistry and Engineering Laboratory at the University of Ottawa Heart Institute Dr. Emilio Alarcon has been named a recipient of nearly $200,000 in research funding from the New Frontiers in Research Fund’s 2018...
Scientist in the Division of Cardiac Surgery, and Director of the Bio-Nanomaterials Chemistry and Engineering Laboratory at the University of Ottawa Heart Institute Dr. Emilio Alarcon has been named a recipient of nearly $200,000 in research funding from the New Frontiers in Research Fund’s 2018...
The Heart Institute has played a pivotal role toward preventing a serious complication following open-chest surgery by helping launch Rhythm Biotherapeutics Inc.
Heart Institute researchers have completed the first major review of studies looking at how tobacco-free nicotine pouches affect smoking habits
The Acute Cardiac Triage Unit is designed to provide rapid, expert assessment and care for patients with cardiac concerns